Allulose powder
A low-calorie rare sugar (also called D-psicose) that tastes like sugar but contributes ~0.4 kcal/g and minimally affects blood glucose.
Should I eat Allulose powder?
Allulose powder is a highly refined rare sugar that tastes like sugar but adds very few calories and has minimal impact on blood sugar. Most adults tolerate modest amounts well, but large single doses can cause GI upset, and EU approval remains pending due to data gaps.
Summary
Human studies show allulose can blunt post‑meal glucose when 5–10 g is consumed with carbohydrates, aligning with U.S. labeling that counts 0.4 kcal/g and excludes it from “Total” and “Added Sugars.” The main practical limit is digestive tolerance, which declines above ~0.4 g/kg per serving or ~0.9 g/kg per day. Labels in the U.S. may be confusing because allulose is a carbohydrate but not counted as sugar; check ingredient lists and serving sizes. Outside the U.S., it is not authorized in the EU and not listed by Health Canada, reflecting ongoing data needs rather than proven harm.
Key Research Benefits
Key Research Risks
Overview
What is it?
Why is it used?
Origin
Allulose (D-psicose) was first identified over a century ago as a rare ‘cousin’ of fructose found in tiny amounts in figs and raisins. Japanese researchers later discovered enzymes (D-psicose 3-epimerases) that flip one hydroxyl group on fructose to create allulose efficiently. In the 2010s, US and Asian companies brought food-grade allulose to market after GRAS notices; by 2019 the FDA said it would exercise discretion to exclude it from ‘Total’ and ‘Added Sugars’ on labels and allow 0.4 kcal/g for calories.
Process: Enzymatic epimerization; purify and crystallize
Steps
Chemicals
Research & Safety
Research Summary
Digestive Effects
Tolerance varies by person and dose. A practical guide is to keep any single serving under ~0.4 g/kg body weight (about 28 g for a 70‑kg adult) and total daily intake under ~0.9 g/kg to minimize laxative effects. Common symptoms at higher intakes include gas, bloating, cramping, and loose stools; these are usually dose‑related and improve when intake is split across meals. People with sensitive guts (e.g., IBS) and children may react at lower amounts.
Limit Consumption
Allulose is not intended for infant formula in GRAS notices, and there is little data in infants, so it should not be used for that purpose. Children and people with IBS or functional GI disorders may experience gas or diarrhea at lower doses, so conservative serving sizes and splitting intake are prudent. For people with diabetes, the minimal glycemic response can be helpful, but monitoring is still wise because other carbohydrates in the food may affect glucose. In the EU and Canada, limited authorization means availability is restricted and safety evaluations are ongoing; follow local regulations and guidance.
Fact Sheet
Regulatory Status
ESG & Sustainability
Allergens and Diet
Natural Alternatives
Honey
Date paste
Inulin
Citations
Guidance for Industry: The Declaration of Allulose and Calories from Allulose
2020-10-06US FDA • US FDA
GRAS Notice 828 – D-psicose (D-allulose)
2020-03-13Samyang Corp. • FDA GRAS
GRAS Notice 1029 – D-psicose (D-allulose)
2022-06-07Bonumose, Inc. • FDA GRAS
Effects of D-allulose on glucose tolerance and insulin response in healthy humans
2021-04-08Franchi F., et al. • BMJ Open Diabetes Research & Care
Safety of D-allulose as a novel food pursuant to Regulation (EU) 2015/2283 (e9468)
2025-06-05EFSA NDA Panel • EFSA Journal
List of Permitted Sweeteners
2024-12-18Health Canada • Health Canada
Gastrointestinal Tolerance of D-Allulose in Healthy and Young Adults
2018-12-18Han Y., et al. • Nutrients
Effect of different sweeteners on cookie dough properties (browning observation)
2024-01-30Zhang J., et al. • Food Chemistry